Erika Hamilton: Proud of the message Sara Sidner shared on CNN
Erika Hamilton shared a post by Sarah Cannon Research Institute on LinkedIn:
“When public figures share their cancer diagnoses (although certainly not required or expected), it improves awareness and screening for women that identify with them and have a ‘this could be me’ moment.
Proud of the message Sara Sidner shared on CNN this week encouraging ALL women to be screened and aware of their bcsm risk even if they too have no family history of breast cancer.”
Quoting Sarah Cannon Research Institute’s post:
“SCRI expert, Dr. Erika Hamilton, joins Scripps News to discuss breast cancer awareness and screening following CNN’s anchor Sara Sidner’s recent announcement about undergoing treatment for stage 3 breast cancer.”
Source: Erika Hamilton/LinkedIn and Sarah Cannon Research Institute/LinkedIn
Erika Hamilton is a medical oncologist and the Director of Breast Cancer and Gynecologic Cancer Research at Sarah Cannon Research Institute (USA). In her role, Dr. Hamilton oversees the research program and clinical trial menu for gynecologic and breast cancer from a medical oncology perspective.
Dr. Hamilton is a past chair of ASCO’s Scientific Breast Committee a ’21-’22, participant of the ASCO Leadership Development Program, Associate Editor for Clinical Breast Cancer, co-chair for Great Debates and Updates in Women’s Oncology Conference and a board member of the Susan G. Komen Foundation of Central Tennessee.
She is active in the community, volunteering with Gilda’s Club Middle Tennessee, the American Cancer Society’s Hope Lodge, Ovarcome ovarian cancer support organization, Brentwood Baptist Church and the Susan G. Komen Race for the Cure.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023